Paper Details
- Home
- Paper Details
Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia.
Author: BlaeschkeFranziska, Cabanillas StanchiKarin Melanie, DöringMichaela, EbingerMartin, EikemeierMelinda, FeuchtJudith, FeuchtingerTobias, HandgretingerRupert, HeinzWerner J, KlinkerHartwig, SchwarzeCarl-Philipp
Original Abstract of the Article :
Invasive fungal infections are one of the major complications in pediatric patients during prolonged neutropenia after chemotherapy. Evaluation of the efficacy and safety of the triazole posaconazole in these patients is missing. This multicenter survey analyzed trough concentrations of 33 pediatric...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1093/mmy/myw091
データ提供:米国国立医学図書館(NLM)
Posaconazole for Pediatric Patients: A New Approach to Fungal Infections
The realm of [pediatric oncology] is often fraught with challenges, like navigating a treacherous desert landscape, seeking to protect young lives from the dangers of [invasive fungal infections]. This study, like a skilled caravan leader, investigates the use of [posaconazole], an antifungal medication, for preventing fungal infections in pediatric patients undergoing chemotherapy. The researchers analyzed the plasma concentrations of posaconazole in a group of pediatric patients, evaluating its efficacy and safety.
Posaconazole: A Shield Against Fungal Infections
The study's findings suggest that [posaconazole] is [effective and safe] for preventing [invasive fungal infections] in pediatric patients with [neutropenia]. It’s like a protective shield against the scorching sun, safeguarding young patients from the harmful effects of fungal infections. The study's results are encouraging, providing a valuable tool for managing this potentially life-threatening complication in pediatric oncology.
Preventing Infections: Navigating the Desert of Chemotherapy
This research highlights the importance of developing effective preventive measures for [invasive fungal infections] in pediatric patients undergoing chemotherapy. It’s like finding a hidden spring in a desert, offering a source of hydration and protection for vulnerable individuals. The study’s findings underscore the importance of continued research and development in the field of pediatric oncology, seeking to find innovative solutions for managing the challenges associated with cancer treatment. This research offers a beacon of hope for young patients facing the arduous journey of chemotherapy.
Dr.Camel's Conclusion
This study provides valuable insights into the use of [posaconazole] for preventing [invasive fungal infections] in pediatric patients undergoing chemotherapy. The researchers, like diligent desert guides, have charted a safer path for young patients facing the challenges of cancer treatment. The study’s findings underscore the importance of tailored treatment approaches, recognizing the unique needs and vulnerabilities of children. It’s a reminder that even in the most challenging deserts, there is always a chance for a brighter future.
Date :
- Date Completed 2018-02-12
- Date Revised 2018-02-12
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.